Cigna to Preauthorize Genetic Tests
Clinical laboratories and pathology groups serving Cigna beneficiaries can expect to see new requirements for genetic tests used to diagnose breast cancer, colon cancer and long QT syndrome Effective this week, Cigna (NYSE: CI) in Bloomfield, Connecticut, is implementing a new program that requires genetic counseling and pre-authorization for certain genetic tests. This is an important […]
Source: Dark Daily - Category: Laboratory Medicine Authors: Barbara Tags: Coding, Billing, and Collections Laboratory Management and Operations Laboratory News Laboratory Operations Laboratory Pathology Laboratory Sales and Marketing Management & Operations News From Dark Daily Amber Trevidi breast cancer ci Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Colon Cancer | Colorectal Cancer | Genetics | Laboratory Medicine | Long QT Syndrome | Marketing | Medical Billing | Pathology